Samsung C&T: Valuation Sensitivity Analysis & Key Catalysts
We provide an updated valuation of Samsung C&T and key catalysts of the company. Our base case valuation of Samsung C&T is implied price of 231,387...
443 Views
Innovent Biologics Placement - Momentum Is Very Strong but past Deals Have Been Mixed
Innovent Biologics Inc (1801 HK) is looking to raise about U$600m to fund its clinical trials and product licensing and possible M&A. This will be...
425 Views
Ocumension Theraputics Placement - IPO Was Hot, Deal Should Be Supported Despite Lock-Up Expiry
Ocumension Therapeutics (1477 HK) aims to raise around US$103m to commercialize new products, fund clinical trials and develop new facilities.
277 Views
Can You Profit from the KR Retail Investor? (Btw You Already Probably Have Met Him)
I wanted to share my thoughts as I follow the retail moves and share not only who the powerful or mover/shaker Korean retail investor as they now...
393 Views
Asia Short Interest: BIG Covering in HK & Korea
There was a big drop in short interest in Hong Kong and Korea while shorts rose in Japan mainly led by ANA on the back of the offering. Shorts in...
345 Views